Punjab Chemicals and Crop Protection Limited Q2 & H1 FY26 Concall Decoded: – Recovery is here, margins still on life support

1. Opening Hook

After two years of chemical winter, Punjab Chemicals finally smelled spring. Not a full-blown boom—more like cautious optimism with gumboots on. Exports are back, volumes are moving, new molecules are knocking, and management sounds relieved rather than euphoric.

But before anyone pops champagne, EBITDA margins are still sulking near 10–11%, floods messed up operations, fuel prices spiked at the worst time, and domestic agro demand decided to misbehave thanks to unseasonal rains.

This concall wasn’t about fireworks. It was about survival, recovery, and laying bricks quietly while waiting for pricing to wake up. The company is clearly positioning itself for the next upcycle—but the bridge from “volumes are back” to “profits are back” is still under construction.

Read on. The molecule pipeline sounds exciting, but the margin math needs patience.

2. At a Glance

Revenue up 5.4% YoY (Q2) – Growth returned, but didn’t exactly sprint.
H1 revenue up 18.6% – Base effect finally doing some heavy lifting.
EBITDA margin at 10.3% – Floods + fuel = margin heartburn.
Exports ₹140 cr in Q2 – Global customers showed up on time.
New products at 16% of sales – Slowly stealing the spotlight.
Capacity utilization healthy – Plants busy, wallets less so.

3. Management’s Key Commentary

“The industry is showing signs of recovery after a prolonged correction.”
(Translation: We survived the worst. Please don’t jinx it.) 😌

“Pricing remains stable at lower levels.”
(Translation: Volumes are back, pricing still asleep.)

“Exports have revived as global inventories normalized.”
(Translation: Customers finally ran out of stock and remembered our number.)

“EBITDA margin took a 1% hit due to floods and fuel shock.”
(Translation: Weather has better pricing power than we do.) 😐

“New molecules are gaining traction in domestic and export markets.”
(Translation: Old products pay bills, new ones might pay bonuses.)

“Over the long term, we target 16–18% EBITDA margins.”
(Translation: Not this year. Please wait.)

“We will commercialize all five products in FY26.”
(Translation: R&D pipeline execution is now non-negotiable.)

4. Numbers Decoded

Source table

Metric	Q2 FY26	H1 FY26	What It Really Means
Revenue	₹255.2 cr	₹574.7 cr	Growth visible, but not explosive
Gross Margin	39.5%	~36%	Product mix & inventory

To Read Full 16 Point

Continue reading with a premium membership.